Ezricare artificial tears, Delsam pharm’s artificial tears eye drops not registered with us – FDA
The Food and Drugs Authority (FDA) has cautioned the general public about a recent major incidence of contamination of two brands of eyedrops, namely; Ezricare Artificial Tears and Delsam Pharma’s Artificial Tears owned by Global Pharma.
A statement issued by the FDA on Thursday, 23 March 2023, said Global Pharma has since “issued a recall of the products.”
Also, “the US Centre for Disease Control and Prevention (USCDC) has classified the incident as an outbreak."
It indicated that the eyedrops were found to contain the “drug-resistant bacteria pseudomanias aeruginosa and is suspected to have led to three deaths and vision loss in eight patients.”
It revealed that the products are not “registered with the Ghana FDA.”
The FDA advised persons in possession of such drugs through other means “to immediately stop using the recalled products, Ezricare Artificial Tears and Delsam Pharma’s Artificial Tears, and submit them to any of the FDA offices nationwide.”
It further advised “anyone who has used these recalled products and is experiencing any symptoms to contact a healthcare professional immediately.”
Reported symptoms include “yellow, green or clear discharge from the eye, eye pain or discomfort, redness, feeling of something in the eye, increase sensitivity to light and blurred visions.”
The FDA assured the general public that it is “taking all necessary measures to ensure that only safe and effective medical products are available in Ghana.”
Source: classfmonline.com/Elikem Adiku
Trending News
Lagos officials praise Jospong Group’s eco-friendly waste management module, eyes similar module
12:57IMF: Failure to agree Eurobond deal 'won't stop us from providing more financing to Ghana'
08:41Scores of Kumasi residents demonstrate over dumsor
10:49'It's no crime' – Abu Sakara defends Alan's NPP exit
12:52Growth to rise from 3.4% to 3.8% for Sub-Saharan Africa
08:22'How could Kutsoatsi attend a Jan-2014 meeting when he took office in April 2014?' - Cocobod RM&E Dir. exposes state witness on alleged Opuni order to cut Lithovit test
11:03Ashanti ECG workers go red, ban managers from security meetings over GM's arrest
12:09Debt restructuring: No MoU reached with bilateral creditors – IMF
08:19Ghana-Vietnam deepen relations
07:582024 polls: Our ‘real challenge’ is getting ‘un-bothered’ youth to vote – ARC’s Abu Sakara
12:53